Showing results (371-380 of 400) with videos related to

Sort By:
Pageof 40
Frontiers in Immunology|April 11, 2019
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease OutcomeFergal J Duffy, January Weiner, Scott Hansen, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2021
Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza: A Clinical StudySuzanna Paterson, Satwik Kar, Seng Kuong Ung, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 12, 2013
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicityJ S Sutherland, A G Loxton, M C Haks, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in AfricaGillian F Black, Bonnie A Thiel, Martin O Ota, et al.
Nature|August 15, 2014
AhR sensing of bacterial pigments regulates antibacterial defencePedro Moura-Alves, Kellen Faé, Erica Houthuys, et al.
Nature Microbiology|April 24, 2024
Age and sex influence antibody profiles associated with tuberculosis progressionLeela R L Davies, Chuangqi Wang, Pia Steigler, et al.
Thorax|May 6, 2016
Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TBNovel N Chegou, Jayne S Sutherland, Stephanus Malherbe, et al.
Nature Communications|December 8, 2018
Metabolite changes in blood predict the onset of tuberculosisJanuary Weiner, Jeroen Maertzdorf, Jayne S Sutherland, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
CXCL5 drives neutrophil recruitment in TH17-mediated GNErik M Disteldorf, Christian F Krebs, Hans-Joachim Paust, et al.
The Lancet. Infectious Diseases|June 30, 2022
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trialMark F Cotton, Shabir A Madhi, Angelique K Luabeya, et al.
Pageof 40